Statistics
Publications
2
Citations
54
H-Index
2
Active since
2019
Affiliations
Tohoku University(Current)
Daichi Toyosawa is an author at Tohoku University specializing in therapeutic resistance, medicine, and cdk inhibitors.
Publications per year
2019–2020
2
2
The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer
Masafumi Iida, Misato Nakamura, Emi Tokuda et al. · Oncotarget · 2019 · 33 citations · Full text
Medicine, Oncology, Pharmacology +17
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
Masafumi Iida, Daichi Toyosawa, Misato Nakamura et al. · Breast Cancer · 2020 · 21 citations
1–2 of 2